We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Gastric

News List

Amgen to Acquire Five Prime Therapeutics for $1.9B contractpharma
March 05, 2021
Amgen entered an agreement to acquire Five Prime Therapeutics for approximately $1.9 billion in cash. This acquisition adds Five Prime's innovative pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
T2DM Increases Gastric Cancer Risk After H. Pylori Eradication drugs
July 24, 2019
Type 2 diabetes mellitus increases the risk for gastric cancer after treatment for Helicobacter pyloriinfection, according to a study published online in Diabetes Care.
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer drugs
June 04, 2019
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer.
Roche launches HER2 biomarker test for breast and gastric cancer pharmatimes
May 09, 2019
Roche has launched a new assay that can detect the HER2 biomarker in breast and gastric cancer in the UK.